QUADRIA CAPITAL
QUADRIA CAPITAL is a Series C+ and buyout fund in India, Indonesia, South Asia and Southeast Asia writing $10M–$50M checks into healthcare-delivery, life-sciences, medical-technology, pharmaceuticals and diagnostics.
- Stages
- Series C+, buyout
- Sectors
- healthcare-delivery, life-sciences, medical-technology, pharmaceuticals, diagnostics
- Check size
- $10M–$50M
- Invests in
- India, Indonesia, South Asia, Southeast Asia
- Actively investing
- Yes
- Founded
- 2012
- Assets under management
- $4.2B
- Website
- quadriacapital.com
Thesis
Quadria Capital is an independent private equity firm exclusively focused on the healthcare sector across Asia. Established in 2012, the firm manages over $4.2 billion in AUM and invests in companies aiming to enhance healthcare access, quality, and affordability. Their strategy centers on providing growth capital to healthcare businesses with strong growth potential and impactful solutions, targeting companies across the healthcare continuum including delivery, life sciences, medical technology, pharmaceuticals, and diagnostics. Quadria primarily focuses on small to mid-market companies in South and Southeast Asia, with a significant emphasis on India and Indonesia. They employ a concentrated growth-equity strategy, often seeking control or significant minority positions with board representation. Quadria emphasizes an 'impact thesis' for each deal, integrated through a proprietary Impact Management and Measurement (IMM) framework. Fund III closed at $1.07 billion. Typical check sizes range from $10 million to $50 million. The firm has offices in Singapore, New Delhi, Vietnam, and Indonesia.
Common questions
Does QUADRIA CAPITAL invest at the Series C+ stage?
Yes. QUADRIA CAPITAL lists Series C+ and buyout among the stages it invests in.
What check size does QUADRIA CAPITAL write?
QUADRIA CAPITAL writes $10M–$50M checks.
Where does QUADRIA CAPITAL invest?
QUADRIA CAPITAL invests in India, Indonesia, South Asia and Southeast Asia.